Believe International

Believe Bio-Med is a clinical-stage biotechnology company specializing in the development of innovative gene therapies using adeno-associated virus (AAV) vectors. Founded by gene therapy pioneer Dr. Xiao Xiao, the company focuses on treating rare diseases and chronic conditions with high unmet medical needs, including hemophilia and neuromuscular disorders. Its lead candidate, BBM-H901, is a Phase 3 gene therapy for Hemophilia B that has demonstrated significant efficacy and safety in clinical trials. Believe Bio-Med maintains integrated capabilities across vector design, process development, and large-scale GMP manufacturing, positioning itself as a leader in the Chinese gene therapy sector.